Showing 1 - 2 of 2
&D acquisitions, turn out to be complementary innovation activities at higher levels of in-house R&D investments, whereas at lower …
Persistent link: https://www.econbiz.de/10008629988
The life sciences sector (and biotechnology in particular) has emerged as a prospective area, and attracted a lot of attention recently. Multinational companies in the life sciences seek to explore new markets, and, on the other side, governments strive to develop the life sciences sector...
Persistent link: https://www.econbiz.de/10005150773